Correlation Between Rxsight and Neuropace
Can any of the company-specific risk be diversified away by investing in both Rxsight and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rxsight and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rxsight and Neuropace, you can compare the effects of market volatilities on Rxsight and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rxsight with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rxsight and Neuropace.
Diversification Opportunities for Rxsight and Neuropace
Significant diversification
The 3 months correlation between Rxsight and Neuropace is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Rxsight and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Rxsight is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rxsight are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Rxsight i.e., Rxsight and Neuropace go up and down completely randomly.
Pair Corralation between Rxsight and Neuropace
Given the investment horizon of 90 days Rxsight is expected to generate 25.5 times less return on investment than Neuropace. But when comparing it to its historical volatility, Rxsight is 1.1 times less risky than Neuropace. It trades about 0.02 of its potential returns per unit of risk. Neuropace is currently generating about 0.5 of returns per unit of risk over similar time horizon. If you would invest 1,054 in Neuropace on February 17, 2025 and sell it today you would earn a total of 695.00 from holding Neuropace or generate 65.94% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Rxsight vs. Neuropace
Performance |
Timeline |
Rxsight |
Neuropace |
Rxsight and Neuropace Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Rxsight and Neuropace
The main advantage of trading using opposite Rxsight and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rxsight position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.Rxsight vs. Axogen Inc | Rxsight vs. Treace Medical Concepts | Rxsight vs. Pulmonx Corp | Rxsight vs. Orthofix Medical |
Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Integer Holdings Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |